Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Pdl Biopharma Inc (PDLI)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q1 | 0 | 0.00 | Sell 100.00% | SEC | |||
| 2017 Q4 | 2,800 | 0.00 | $2.86 | $8,000 | SEC | ||
| 2017 Q3 | 2,800 | 0.00 | $3.21 | $9,000 | SEC | ||
| 2017 Q2 | 2,800 | 0.00 | $2.50 | $7,000 | SEC | ||
| 2017 Q1 | 2,800 | 0.00 | $2.14 | $6,000 | SEC | ||
| 2016 Q4 | 2,800 | 0.00 | $2.14 | $6,000 | SEC | ||
| 2016 Q3 | 2,800 | 0.00 | $3.21 | $9,000 | SEC | ||
| 2016 Q2 | 2,800 | 0.00 | $3.21 | $9,000 | SEC | ||
| 2016 Q1 | 2,800 | 0.00 | $3.21 | $9,000 | SEC | ||
| 2015 Q4 | 2,800 | 0.00 | $3.57 | $10,000 | SEC | ||
| 2015 Q3 | 2,800 | 0.00 | $5.00 | $14,000 | SEC | ||
| 2015 Q2 | 2,800 | 0.00 | $6.43 | $18,000 | SEC | ||
| 2015 Q1 | 2,800 | 0.00 | $7.14 | $20,000 | SEC | ||
| 2014 Q4 | 2,800 | <0.01 | $7.86 | $22,000 | SEC | ||
| 2014 Q3 | 2,800 | <0.01 | $7.50 | $21,000 | SEC | ||
| 2014 Q2 | 2,800 | <0.01 | $9.64 | $27,000 | SEC | ||
| 2014 Q1 | 2,800 | <0.01 | $8.21 | $23,000 | SEC | ||
| 2013 Q4 | 2,800 | <0.01 | $8.57 | $24,000 | SEC | ||
| 2013 Q3 | 2,800 | <0.01 | $7.86 | $22,000 | SEC | ||
| 2013 Q2 | 2,800 | <0.01 | Buy | <0.01 | $7.86 | $22,000 | SEC |